Research had indicated that inhibiting SENP1 in breast cancer, hepatocellular carcinoma and prostate cancer could impact their proliferation, invasion and migration, and also plays an important role in brain injury, heart injury, lung injury, liver injury.10 Here, SENP1 is linked to breast carcinoma.